ArticleBMC complementary medicine and therapies2025
Herbal products use during pregnancy and postpartum: study of consumption and user profile in Catalonia.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Perceptions on the use of medicines, vaccines, and alternative medicine during pregnancy and breastfeeding: Population-based survey in Catalonia, Spain.European journal of midwifery · 2026Article
- Self-Medication With Herbal Remedies During Pregnancy: Practices, Reasons, and Adverse Effects.Scientifica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of herbal products (HPs) consumption among pregnant and postpartum women, the factors driving their use or the main sources of recommendation have never been studied in Spain or Catalonia. Investigating its prevalence of use during critical phases of development is crucial for providing guidance to health professionals.
methodsA validated questionnaire, containing general data on socio-demographic status, lifestyle, maternal health data and its association with HP consumption, was performed in online personal interviews among women living in Catalonia between pregnancy week 22 and postpartum month 9.
resultsWe identified a higher percentage of HPs consumption compared to other European countries, while the 5 most consumed products were similar to the products described to be consumed by pregnant women in other countries. The most frequently consumed HPs were ginger (28%), chamomile (9%), thyme (7%), rooibos (6%), cranberry (4%), and raspberry leaf (4%), and we identified specific temporal patterns of consumption for several of them, depending on the trimester of pregnancy. Furthermore, we found a significant relationship between women consuming oral HPs and the opinion that "pregnant women should preferably consume herbal remedies rather than conventional medicines".
conclusionsWe provide evidence that women consuming HPs during pregnancy are not defined by a specific profile and therefore, healthcare professionals should be aware that any woman could potentially consume HPs during this period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.